Samsara Biocapital Gp, Llc - Net Worth and Insider Trading
Samsara Biocapital Gp, Llc Net Worth
The estimated net worth of Samsara Biocapital Gp, Llc is at least $336 Million dollars as of 2025-06-02. Samsara Biocapital Gp, Llc is the 10% Owner of Scholar Rock Holding Corp and owns about 6,788,609 shares of Scholar Rock Holding Corp (SRRK) stock worth over $198 Million. Samsara Biocapital Gp, Llc is the 10% Owner of Mineralys Therapeutics Inc and owns about 5,674,916 shares of Mineralys Therapeutics Inc (MLYS) stock worth over $89 Million. Samsara Biocapital Gp, Llc is also the 10% Owner of Neurogene Inc and owns about 1,717,127 shares of Neurogene Inc (NGNE) stock worth over $30 Million. Besides these, Samsara Biocapital Gp, Llc also holds Cargo Therapeutics Inc (CRGX) . Details can be seen in Samsara Biocapital Gp, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samsara Biocapital Gp, Llc has not made any transactions after 2025-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Samsara Biocapital Gp, Llc
Samsara Biocapital Gp, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Samsara Biocapital Gp, Llc owns 1 companies in total, including Scholar Rock Holding Corp (SRRK) .
Click here to see the complete history of Samsara Biocapital Gp, Llc’s form 4 insider trades.
Insider Ownership Summary of Samsara Biocapital Gp, Llc
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 2023-10-16 | 10 percent owner |
Samsara Biocapital Gp, Llc Latest Holdings Summary
Samsara Biocapital Gp, Llc currently owns a total of 4 stocks. Among these stocks, Samsara Biocapital Gp, Llc owns 6,788,609 shares of Scholar Rock Holding Corp (SRRK) as of October 16, 2023, with a value of $198 Million and a weighting of 58.85%. Samsara Biocapital Gp, Llc owns 5,674,916 shares of Mineralys Therapeutics Inc (MLYS) as of March 13, 2025, with a value of $89 Million and a weighting of 26.56%. Samsara Biocapital Gp, Llc also owns 1,717,127 shares of Neurogene Inc (NGNE) as of November 26, 2024, with a value of $30 Million and a weighting of 8.94%. The other 1 stocks Cargo Therapeutics Inc (CRGX) have a combined weighting of 5.65% among all his current holdings.
Latest Holdings of Samsara Biocapital Gp, Llc
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 2023-10-16 | 6,788,609 | 29.14 | 197,820,066 |
| MLYS | Mineralys Therapeutics Inc | 2025-03-13 | 5,674,916 | 15.74 | 89,294,803 |
| NGNE | Neurogene Inc | 2024-11-26 | 1,717,127 | 17.50 | 30,049,723 |
| CRGX | Cargo Therapeutics Inc | 2024-05-30 | 4,415,689 | 4.30 | 18,987,463 |
Holding Weightings of Samsara Biocapital Gp, Llc
Samsara Biocapital Gp, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 1 transactions in Scholar Rock Holding Corp (SRRK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Scholar Rock Holding Corp is the acquisition of 2,189,781 shares on October 16, 2023, which cost Samsara Biocapital Gp, Llc around $15 Million.
According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 2 transactions in Mineralys Therapeutics Inc (MLYS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Mineralys Therapeutics Inc is the acquisition of 600,000 shares on March 13, 2025, which cost Samsara Biocapital Gp, Llc around $8 Million.
According to the SEC Form 4 filings, Samsara Biocapital Gp, Llc has made a total of 1 transactions in Neurogene Inc (NGNE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Neurogene Inc is the acquisition of 48,770 shares on November 26, 2024, which cost Samsara Biocapital Gp, Llc around $1 Million.
More details on Samsara Biocapital Gp, Llc's insider transactions can be found in the Insider Trading History of Samsara Biocapital Gp, Llc table.Insider Trading History of Samsara Biocapital Gp, Llc
- 1
Samsara Biocapital Gp, Llc Trading Performance
GuruFocus tracks the stock performance after each of Samsara Biocapital Gp, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samsara Biocapital Gp, Llc is 19.19%. GuruFocus also compares Samsara Biocapital Gp, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samsara Biocapital Gp, Llc within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Samsara Biocapital Gp, Llc's insider trading performs compared to the benchmark.
Performance of Samsara Biocapital Gp, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.44 | | | | | |
| Relative Return to S&P 500(%) | 0.3 | | | | | |
Samsara Biocapital Gp, Llc Ownership Network
Ownership Network List of Samsara Biocapital Gp, Llc
Ownership Network Relation of Samsara Biocapital Gp, Llc
Samsara Biocapital Gp, Llc Owned Company Details
What does Scholar Rock Holding Corp do?
Who are the key executives at Scholar Rock Holding Corp?
Samsara Biocapital Gp, Llc is the 10 percent owner of Scholar Rock Holding Corp. Other key executives at Scholar Rock Holding Corp include Chief Commercial Officer Tracey Sacco , other: SVP & Finance Erin Moore , and SVP and Head of Research Mo Qatanani .
Scholar Rock Holding Corp (SRRK) Insider Trades Summary
Over the past 18 months, Samsara Biocapital Gp, Llc made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 464,276 shares made by Edward H Myles , a net sale of 113,419 shares made by Mo Qatanani , and a net sale of 24,086 shares made by Caryn Parlavecchio .
In summary, during the past 3 months, insiders sold 201,437 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 201,437 shares. During the past 18 months, 4,069,959 shares of Scholar Rock Holding Corp (SRRK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,069,959 shares.
Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Scholar Rock Holding Corp Insider Transactions
Samsara Biocapital Gp, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Samsara Biocapital Gp, Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Samsara Biocapital Gp, Llc's mailing address is: Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
